Participated · Series C · May 2025

Empathy offers a loss-support platform and recently expanded into legacy planning with Empathy LifeVault, which enables creation and secure storage of legally binding estate plans and documents. The company integrates AI to improve the Care Team’s speed, accuracy, and automation while maintaining human-led support. Empathy reports coverage for over 45 million lives and handles one in five U.S. life insurance claims beyond the payout. Its offerings are distributed through partnerships with eight of the top ten U.S. life insurers and more than one thousand employers, and are available across North America, including every U.S. state and Canada. In the past four months, seven million individuals have received access to LifeVault through partners such as Aflac and New York Life. Empathy says it plans to deepen capabilities, accelerate product innovation, scale platform offerings, and expand its support ecosystem to reach more families during difficult moments. Empathy offers a bereavement-care platform that mixes AI tooling with human guides to support tasks from counseling and obituary writing to shutting down digital accounts and settling complex financial affairs. The company primarily sells via a B2B2C model through employers and insurers, which account for 99% of its business. Empathy reports some 40 million people using its platform (about 5 million employees and 35 million policyholders). The startup was founded in Israel and maintains R&D there while focusing its commercial efforts in the U.S.; it launched in the U.S. in 2021. Leadership includes CEO and co-founder Ron Gura and co-founder Yonatan Bergman. The company plans to use new funding to build more AI tools and continue its mission to “redefine bereavement care” while keeping human teams for empathetic services. Empathy offers a digital assistant that guides bereaved executors and families through practical tasks (estate paperwork, taxes) and emotional support (links to counseling and other resources). Its technology was built in Israel and the company chose to launch in the U.S. Early traction has been strong: about 250,000 bereaved executors visit and use Empathy’s services each month, and the company says it has captured a "nice, single-digit percent" of the market. Empathy is expanding partnerships with stakeholders in the end-of-life process, and to date some 300 cemeteries and 72 funeral homes refer customers to the service. The product mix includes wholly free resources as well as paid services. To support growth and keep up with demand, Empathy recently raised new capital; the company is not disclosing its valuation. Empathy combines technology and human support to provide a digital companion application that empowers bereaved families. The software streamlines end-of-life bureaucracy, minimizes tedious tasks, and automates processes involved in the administration of an estate. The team includes professionals from legal, accounting, product design, engineering, and cybersecurity, alongside grief experts who support families. Empathy launched its application on iOS and Android for users across the United States. The company intends to use its recent funding to continue expanding operations and its business reach. Empathy is led by founders Ron Gura and Yonatan Bergman and is based in New York and Tel Aviv, Israel.

Participated · Series C · Feb 2023

Ushur offers a platform with dashboards and templated, no-code workflows that let business teams build AI-powered automations and connect existing systems via APIs and data connectors. Its product set includes conversational AI, intelligent document processing (models trained on industry forms like ACORD), email-triage models, and a chatbot-like plugin that works across web, mobile, email and live chat. The company targets enterprises in heavily regulated industries including insurance, healthcare, financial services and banking and counts customers such as Aflac, Aetna, CVS Health and United Healthcare; more than half of its clients are Fortune 500 companies and it serves three of the world’s top six healthcare firms. Ushur says the pandemic accelerated growth — it more than doubled its customer base, tripled headcount, expanded across three continents, and the last four quarters were the biggest in company history; annual recurring revenue in 2022 eclipsed the total for the previous four years combined. The company has 203 employees and plans to hire this year. Management plans to expand the product portfolio, develop new AI innovations and move into new regions, industry verticals and the public sector within the next 12 months. Ushur provides a no-code intelligent automation platform that uses natural-language processing and conversational AI to automate high-contact customer interactions into self-service workflows. The platform includes a no-code visual builder, tools for data extraction, and integrations with back-end core systems to accelerate time to value. Ushur serves insurance, finance and healthcare customers and counts HealthSpire, Irish Life and Unum among its users. The company is headquartered in Santa Clara and maintains an office in Bangalore. Financially, Ushur expanded its Series B with a $5M extension that brought the round to $30M and increased cumulative funding to $41.5M. The company has added a strategic advisory board and senior executive hires from the insurance sector to support go-to-market and product development, and is tapping strategic investors to accelerate expansion in insurance. Ushur offers a no-code, AI-based platform that lets businesses build customized customer communication flows without coding. Its product suite includes Virtual Customer Assistants (chatbots), SmartMail for automated email responses, and FlowBuilder to help customer service agents. The platform provides APIs and integrations with Slack, ServiceNow, Salesforce and Jira, and supports 60 languages. Ushur counts insurance customers such as Aetna, Irish Life, Tower Insurance and Unum and is expanding its focus into financial services and telecoms. The company reports customer efficiency gains—an Irish Life email service reduced processing from hours or days to under a second with 40% fewer resources, per Ushur. Ushur plans to use the new funding primarily to expand sales and marketing after seeing increased demand during the COVID-19 pandemic. Ushur provides a micro-engagement SaaS platform that automates both backend processes and external customer conversations by combining Robotic Process Automation and its Language Intelligence Service Architecture (LISA). The platform offers extensive integrations, APIs, and drag-and-drop visual tools to build automated service workflows. Ushur reports strong engagement and operational metrics for customers, including 90% open rates, 30% click-through rates, 20% reductions in call center costs, and 30% increases in closing rates for insurance use cases. Its solutions are already deployed across insurtech customers for claims processing, sales enablement, bill processing, and eligibility workflows. The company can translate over 60 local languages and reach customers in more than 192 countries. Ushur has offices in Silicon Valley, California and Bangalore, India, and plans to scale its platform to additional enterprise verticals including banking, human resources, and higher education.

Participated · Series A · Oct 2022

TCARE is a St. Louis-based company that provides an evidence-based family caregiver support solution designed to reduce family caregiver burnout. Its technology uses precision targeting and mapping of resources and comprises intelligent machine-learning models, data prediction models, and analytics that pull Social Determinants of Health (SDOH) data. The platform is positioned to create LTSS and LTC population health risk management solutions. TCARE spun out of research from the University of Wisconsin–Milwaukee and reports customers across multiple segments and industries, including enterprise and Fortune 100 clients. The company recently closed an oversubscribed $17 million Series A, bringing total funding to $20 million, led by American Family Ventures with participation from new and returning investors. Management says the growth capital will be used to expand offerings with enterprise customers, grow its footprint with current customers, and enter previously untapped markets. TCARE is a St. Louis-based company offering an enterprise SaaS platform to support family caregivers. Led by CEO Ali Ahmadi, the platform uses predictive analytics to identify and prevent caregiver burnout, aiming to reduce long-term care service usage and delay nursing home placements. The company partners with health, life and long-term care insurance carriers to integrate its solution into payer programs. Its clients include top‑5 MCOs, Managed Long-Term Services and Supports (MLTSS) plans, Medicare health plans, the Washington State Dept. of Social & Health Services, the Alaska Dept. of Health, the Hawaii Office of Aging and 90+ Area Agencies on Aging spanning 32 states. TCARE closed a $3M financing round and intends to use the funds to expand operations and broaden its business reach.

Led · Series B · Apr 2022

Phable builds an AI-enabled health assistant and a full-stack chronic disease management platform that delivers disease-specific guidance and continuous monitoring. Its platform creates an ecosystem linking patients, doctors, hospitals, health devices, insurers and patient care service providers. The company reports more than 3 million patients, over 10,000 doctors and 1,000+ pharmacists using its technology. Phable plans to expand to 30M+ Indian households and 100,000+ super-specialist doctors over the next two years and aims to capture 25% of the market. It intends to accelerate market expansion, customer acquisition, build new revenue streams and further integrate the healthcare system. Founded in 2017 and based in Bengaluru, Phable positions itself as India’s largest chronic disease management provider. Phable has built a full‑stack solution that aggregates transactions for patients with chronic diseases, including teleconsultation, test tracking, medicine purchases and medical IoT device integration. The startup says it has developed what it claims is the world’s largest integration with medical IoT devices and also sells a range of devices through its platform. Its app automatically collects patient data, enables medication tracking and reminders, and lets doctors nudge patients and request follow-ups. Phable maintains partnerships with e‑pharmacies 1mg and Medlife to simplify medicine orders and delivery. The company currently serves more than 220,000 patients and is used by over 5,000 doctors; doctors using the platform have seen their revenue grow by about 20%. Phable employs 72 people and plans to broaden its offering to include in‑app insurance purchases while scaling its user and doctor base. Phable, founded in 2017 and headquartered in Bengaluru, operates a healthcare platform and 'Super App' serving patients, doctors, and hospitals. The app focuses on chronic disease management by providing compliance mechanisms that alert patients about medication intake, lab tests and doctor visits. It leverages AI and machine learning to offer targeted health tips and helps physicians by surfacing a patient’s treatment history. Phable currently offers services in Bengaluru, Hyderabad and Chandigarh and claims to have helped over 50,000 patients and onboarded more than 700 doctors. The company plans geographic expansion—aiming to reach 12 cities by the end of 2020—and says it intends to impact the health of 1.3 billion Indians over the next five years. Financially, it previously raised $150,000 from SOSV in August and $300,000 in 2018 from OmphalosVenture India LLP and angel investors.

Participated · Series B · Apr 2022

PhableCare is an app-based, full-stack chronic disease management platform that connects patients, doctors, pharmacists, device makers, hospitals, e-pharmacies and insurers. Its solution delivers remote consultations, decision-support for doctors, patient engagement, IoT device integration and data-driven disease management. The platform already serves 3M+ patients, 10k+ doctors and 1k+ pharmacists, making it a market leader in India’s chronic-care segment. The company plans to expand to 30M+ Indian households and 100,000+ super-specialist doctors and aims to capture 25% of the market over the next two years. PhableCare will use recent funding to strengthen its full-stack, value-driven chronic-care ecosystem, accelerate customer acquisition and brand building, build new revenue streams, and pursue strategic acquisitions. It has also allocated capital and arranged additional venture-debt to invest in other health-tech startups to expand capacity and capabilities. PhableCare operates a technology platform that creates an ecosystem of patients, doctors, hospitals, health devices, insurance and patient-care service providers to manage chronic diseases. The company provides online doctor consultations and a mobile app that lets patients order medicines, connect health IoT devices (Google Fit, Fitbit, Garmin) and manually or visually upload test results via computer vision. Its platform claims a network of 5,000+ doctors, more than 20,000 booked online consultations, and tracking of over 30 million patients' vitals. The founders say the company aims to reach 5 million patients and 35,000 doctors by the end of the year. PhableCare was founded in 2017 and is led by founders Mukesh Bansal, Sumit Sinha and Prasanth Reddy. To date the startup has raised over $13 million in funding.